More Renerve Limited news
Renerve LimitedASX: RNV

Q1 FY26 Activities Report and Appendix 4C

Oct 22, 2025 at 10:07 PM EDT · Issued by Renerve Limited

Filed with ASX · Oct 22, 2025 at 10:07 PM EDT

On 6ix: 6ix.com/news/q1-fy26-activities-report-and-appendix-4c

Renerve Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Renerve Limited on 6ix

Story so far

  • ReNerve - Appendix 4EAug 29, 2025
  • Q4 FY25 Activities Report and Appendix 4CJul 30, 2025
  • ReNerve - Q3 FY25 Activities Report & Appendix 4CApr 29, 2025

Earlier from Renerve

  • ReNerve achieves first sales of amniotic tissue rangeOct 13, 2025
  • Investor Roadshow PresentationSep 28, 2025
  • Empliq Product LaunchSep 22, 2025
  • ReNerve launches the EmpliQ product rangesSep 22, 2025
  • ReNerve - Appendix 4EAug 28, 2025

Later from Renerve

  • ReNerve Clinical Study ExpansionNov 4, 2025
  • Nerve Cuff approved for use in US DoD and VA hospitalsNov 12, 2025
  • Trading HaltNov 17, 2025
  • ReNerve completes $3.2m capital raisingNov 19, 2025
  • ReNerve AGM PresentationNov 26, 2025
All Renerve news releases↗

Follow Renerve into a list and get an email when it puts out news.

Follow Renerve
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer